Preclinical and Translational Studies

We apply expert knowledge of fundamental biological processes to understand targets in preclinical models and accelerate transition to the next stage of development
Preclinical Capabilities

Ensure that the target IHC assay is ready for your clinical study:

  • Reproducibility & precision testing
  • Large scale sensitivity testing in any tissue type
  • Specificity analysis in cell lines, xenografts, animal tissues, & normal human tissues
  • Scoring scheme development
  • Expression rate analysis for cut-off determination
  • Adherence to applicable GLP guidelines
  • Delivery of IND submission-ready data reports
  • Immuno-Oncology validated assays for many targets in mouse and human
Translational Capabilities

Develop and test your research target:

  • Reproducibility & precision testing
  • Large scale sensitivity testing in any tissue type
  • Specificity analysis in cell lines, xenografts, animal tissues, & normal human tissues
  • Scoring scheme development
  • Expression rate analysis for cut-off determination
  • Evaluation of Pharmacodynamic & Predictive Markers
  • Development of prototype Companion Diagnostic assays
  • Immuno-Oncology validated assays for many targets in mouse and human
Build study cohorts with the characteristics you need using the world’s largest commercial FFPE bioBank

Connect With Us

Submit this form to start a conversation with Discovery to:
1

Begin IHC Service Project
2

Explore FFPE Inventory for IHC Analysis
3

Ask questions about our tissue biomarker solutions